Beta-blockers and plasma triglycerides.
作者信息
Shaw J, England J D, Hua A S
出版信息
Br Med J. 1978 Apr 15;1(6118):986. doi: 10.1136/bmj.1.6118.986-a.
Abstract
摘要
相似文献
1
Beta-blockers and plasma triglycerides.β受体阻滞剂与血浆甘油三酯
Br Med J. 1978 Apr 15;1(6118):986. doi: 10.1136/bmj.1.6118.986-a.
2
[The beta-blockers in hypertension].[高血压中的β受体阻滞剂]
Rev Prat. 1984 Apr 1;34(19):941-50.
3
Beta-blockers and plasma triglycerides.β受体阻滞剂与血浆甘油三酯
Br Med J. 1978 May 20;1(6123):1348. doi: 10.1136/bmj.1.6123.1348.
4
5
Effects of different beta-blockers on lipid metabolism in chronic therapy of hypertension.不同β受体阻滞剂在高血压长期治疗中对脂质代谢的影响。
Int J Clin Pharmacol Ther Toxicol. 1988 Dec;26(12):597-604.
6
The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone.
J Cardiovasc Pharmacol. 1984;6 Suppl 3:S474-6.
7
[Beta blockers in arterial hypertension].[β受体阻滞剂用于动脉高血压治疗]
Soins Cardiol. 1985 Jun-Jul(28-29):31-8.
8
[Principal pharmacological properties of different beta-blockers, possibilities and new perspectives of their uses].
Georgian Med News. 2006 Dec(141):38-46.
9
[Beta-receptor blockers in hypertension: nonselective or selective].
Ned Tijdschr Geneeskd. 1978 Dec 9;122(49):1924-5.
10
Editorial: Beta-blockers for hypertension.社论：用于治疗高血压的β受体阻滞剂
Lancet. 1976 Sep 11;2(7985):551-2.
引用本文的文献
1
Adverse reactions with beta-adrenoceptor blocking drugs. An update.β-肾上腺素受体阻断药的不良反应。最新进展。
Drug Saf. 1993 Oct;9(4):272-9. doi: 10.2165/00002018-199309040-00005.
2
Serum lipoprotein changes during atenolol treatment of essential hypertension.阿替洛尔治疗原发性高血压期间的血清脂蛋白变化
Eur J Clin Pharmacol. 1981;20(5):335-8. doi: 10.1007/BF00615401.
3
Effect of pindolol on serum lipids and lipid metabolizing enzymes.吲哚洛尔对血脂及脂质代谢酶的影响。
Br J Clin Pharmacol. 1982;13(Suppl 2):445S-447S. doi: 10.1111/j.1365-2125.1982.tb01955.x.
4
The short term effects of propranolol, atenolol and labetalol on antipyrine kinetics in normal subjects.普萘洛尔、阿替洛尔和拉贝洛尔对正常受试者安替比林动力学的短期影响。
Br J Clin Pharmacol. 1982 Jun;13(6):817-20. doi: 10.1111/j.1365-2125.1982.tb01872.x.
5
Oxprenolol, methyldopa and lipids in diabetes mellitus.糖尿病患者中的氧烯洛尔、甲基多巴与脂质
Br J Clin Pharmacol. 1982 Feb;13(2):219-22. doi: 10.1111/j.1365-2125.1982.tb01360.x.
6
Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects.阿替洛尔与安慰剂治疗轻度高血压：肾脏代谢及应激抗高血压作用
Br J Clin Pharmacol. 1980 Jun;9(6):553-60. doi: 10.1111/j.1365-2125.1980.tb01080.x.
7
Serum lipids and glucose concentrations in subjects using antihypertensive drugs: Finnmark 1977.使用抗高血压药物的受试者的血脂和血糖浓度：1977年芬马克郡研究
J Epidemiol Community Health. 1983 Jun;37(2):141-4. doi: 10.1136/jech.37.2.141.
8
Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease.短期β-肾上腺素能受体阻滞剂对高血压或冠状动脉疾病患者血脂和脂蛋白的影响。
Br Heart J. 1984 Jun;51(6):589-94. doi: 10.1136/hrt.51.6.589.
9
[Antihypertensive therapy and lipid metabolism].[抗高血压治疗与脂质代谢]
Klin Wochenschr. 1984 Mar 1;62(5):193-202. doi: 10.1007/BF01721044.
10
The effect of two beta-adrenoceptor blockers (mepindolol and atenolol) on blood lipids and platelet aggregation in normal volunteers and essential hypertensive patients.两种β-肾上腺素能受体阻滞剂（美吲哚洛尔和阿替洛尔）对正常志愿者和原发性高血压患者血脂及血小板聚集的影响。
Br J Clin Pharmacol. 1984 Mar;17(3):361-3. doi: 10.1111/j.1365-2125.1984.tb02355.x.
本文引用的文献
1
Beta-blockers and lipid metabolism.β受体阻滞剂与脂质代谢
Br Med J. 1977 Jul 9;2(6079):126. doi: 10.1136/bmj.2.6079.126-a.
2
Metabolic effects of beta-adrenoreceptor blockers.β-肾上腺素能受体阻滞剂的代谢效应
Drugs. 1976;11 SUPPL 1:121-6. doi: 10.2165/00003495-197600111-00027.
Zotero 插件